Position in MRK
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$1,724,470
+$148,912 QoQ
Shares Held
13,420
+2.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
#1,694
of 3,769 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 20%
Shared 0%
None 80%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Hexagon Capital Partners LLC holds $11,707,728 across 11 Drug Manufacturers - General names. MRK ranks #2 (14.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
8,314 | $2,092,134 | |
| 2 | MRK |
Merck & Co., Inc.
This page
|
13,420 | $1,724,470 | |
| 3 | LLY |
ELI LILLY & Co
|
1,184 | $1,420,125 | |
| 4 | PFE |
Pfizer Inc
|
54,852 | $1,320,836 | |
| 5 | JNJ |
Johnson & Johnson
|
5,167 | $1,312,262 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
18,323 | $1,055,771 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
6,901 | $871,872 | |
| 8 | NVS |
Novartis AG
|
3,990 | $625,312 |
All Filings in MRK
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,724,470 | 13,420 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $1,575,558 | 13,098 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $1,605,425 | 15,252 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $1,216,145 | 14,490 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,118,926 | 14,135 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $949,750 | 10,581 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $645,724 | 6,491 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $606,751 | 5,343 | Shares | Sole | 2024-10-08 | |
| 2024-06-30 | $682,509 | 5,513 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $677,959 | 5,138 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $621,850 | 5,704 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $370,208 | 3,596 | Shares | Sole | 2023-10-23 | |
| 2023-06-30 | $461,790 | 4,002 | Shares | Sole | 2023-07-24 | |
| 2023-03-31 | $443,859 | 4,172 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $570,726 | 5,144 | Shares | Sole | 2023-01-13 | |
| 2022-09-30 | $747,521 | 8,680 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $554,951 | 6,087 | Shares | Sole | 2022-07-21 | |
| 2022-03-31 | $418,865 | 5,105 | Shares | Sole | 2022-04-13 | |
| 2021-12-31 | $371,244 | 4,844 | Shares | Sole | 2022-01-27 | |
| 2021-09-30 | $338,670 | 4,509 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $414,358 | 5,328 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $306,201 | 3,972 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $327,608 | 4,005 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $331,053 | 3,991 | Shares | Sole | 2020-11-10 | |
| No filing history on record for this holder in this stock. | ||||||